내시경 치료 기기 시장 기회, 성장 촉진요인, 업계 동향 분석 및 예측(2026-2035년)

The Global Endotherapy Devices Market was valued at USD 5.6 billion in 2025 and is estimated to grow at a CAGR of 7.6% to reach USD 11.7 billion by 2035.

Market expansion is driven by the increasing shift toward minimally invasive treatment approaches, rapid innovation in therapeutic endoscopy technologies, and the growing number of outpatient and ambulatory care facilities. Endotherapy devices are specialized instruments designed to support therapeutic procedures performed through endoscopic access, enabling internal treatment without large surgical incisions. These devices allow clinicians to perform targeted therapeutic interventions with improved accuracy and reduced patient recovery time. Rising procedural volumes across healthcare systems are reinforcing demand for advanced endotherapy solutions. Continuous improvements in visualization quality, device flexibility, energy delivery systems, and automation are enhancing procedural precision and patient safety. These advancements are broadening the range of conditions that can be managed endoscopically, reducing reliance on conventional surgery. Ongoing technology upgrades are also contributing to replacement demand, as healthcare providers prioritize modern systems that deliver better clinical outcomes and operational efficiency.

Endotherapy platforms are becoming increasingly sophisticated, integrating high-definition imaging, enhanced contrast visualization, and advanced optical technologies. These features support improved detection capabilities and more accurate therapeutic delivery, strengthening clinical confidence and improving procedural success rates. Enhanced visualization continues to play a central role in expanding adoption across healthcare facilities.

The gastrointestinal devices and accessories segment accounted for 56.4% share in 2025, supported by consistently high procedure volumes and widespread use of therapeutic tools in routine endoscopic care. The segment maintains its leadership position due to the broad application of gastrointestinal endotherapy across diagnostic and interventional procedures. Growing utilization of endoscopic treatment methods continues to support sustained demand for specialized accessories and devices within this category.

The hospitals segment generated 54.6% share in 2025 and is expected to reach USD 6.2 billion during 2026-2035. Hospitals manage a wide range of patient cases and perform a high volume of complex and multidisciplinary procedures, driving consistent demand for advanced endotherapy technologies. These facilities are equipped with comprehensive endoscopy infrastructure, advanced imaging systems, and specialized clinical expertise, reinforcing their dominance in market adoption.

U.S. Endotherapy Devices Market was valued at USD 2.3 billion in 2025. Strong reimbursement coverage for endoscopic procedures and supportive healthcare funding structures continue to encourage investment in modern endotherapy equipment, sustaining high utilization rates across care settings.

Key companies active in the Global Endotherapy Devices Market include Medtronic, OLYMPUS, Boston Scientific, KARL STORZ, FUJIFILM, Johnson & Johnson, Cook Medical, CONMED, Smith+Nephew, Stryker, B. BRAUN, Endo-Med, MICRO-TECH, M.I. Tech, and TAEWOONG MEDICAL. These companies maintain competitive positions through innovation, product breadth, and global distribution networks. To strengthen their presence, companies in the endotherapy devices sector focus heavily on continuous product innovation and technological differentiation. Strategic investments in advanced imaging, energy-based tools, and device miniaturization enhance clinical performance and usability. Manufacturers are expanding geographic reach through partnerships, acquisitions, and distribution agreements to access high-growth markets. Training programs and physician education initiatives are used to drive adoption and long-term customer loyalty.

Table of Contents

Chapter 1 Research Methodology

• 1.1 Research approach
• 1.2 Quality commitments
  • 1.2.1 GMI AI policy & data integrity commitment
    • 1.2.1.1 Source consistency protocol
• 1.3 Research trail & confidence scoring
  • 1.3.1 Research trail components
  • 1.3.2 Scoring components
• 1.4 Data collection
  • 1.4.1 Partial list of primary sources
• 1.5 Data mining sources
  • 1.5.1 Paid sources
    • 1.5.1.1 Sources, by region
• 1.6 Base estimates and calculations
  • 1.6.1 Base year calculation for any one approach
• 1.7 Forecast model
  • 1.7.1 Quantified market impact analysis
    • 1.7.1.1 Mathematical impact of growth parameters on forecast
• 1.8 Research transparency addendum
  • 1.8.1 Source attribution framework
  • 1.8.2 Quality assurance metrics
  • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Product trends
  • 2.2.3 Application trends
  • 2.2.4 End use trends
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of gastrointestinal disorders
    • 3.2.1.2 Growing demand for minimally invasive procedures
    • 3.2.1.3 High volume of endoscopic procedures
    • 3.2.1.4 Technological advancements in endoscopic devices
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of advanced endotherapy devices
    • 3.2.2.2 Risk of procedure-related complications
  • 3.2.3 Market opportunities
    • 3.2.3.1 Increasing adoption of single-use endotherapy devices
    • 3.2.3.2 Integration of robotics and AI in endotherapy
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
• 3.5 Technology landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Reimbursement scenario
• 3.7 Future market trends
• 3.8 Value chain analysis
• 3.9 Pricing analysis
• 3.10 Start-up scenarios
• 3.11 Consumer insights
• 3.12 Porter's analysis
• 3.13 PESTEL analysis
• 3.14 Gap analysis

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
  • 4.3.1 Global
  • 4.3.2 North America
  • 4.3.3 Europe
  • 4.3.4 Asia Pacific
• 4.4 Competitive positioning matrix
• 4.5 Competitive analysis of major market players
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Gastrointestinal devices & accessories
  • 5.2.1 Biopsy forceps
    • 5.2.1.1 Single-use biopsy forceps
    • 5.2.1.2 Reusable biopsy forceps
    • 5.2.1.3 Hot biopsy forceps
  • 5.2.2 Injection needles
    • 5.2.2.1 EUS-guided FNA (fine needle aspiration) needles
    • 5.2.2.2 EUS-guided FNB (fine needle biopsy) needles
    • 5.2.2.3 Other injection needles
  • 5.2.3 Endoscopic submucosal dissection (ESD) knives
    • 5.2.3.1 Needle-tipped knives
    • 5.2.3.2 Insulation-tipped knives
  • 5.2.4 Polypectomy snares
  • 5.2.5 Hemoclips
  • 5.2.6 Graspers
  • 5.2.7 Hemostasis forceps
  • 5.2.8 Sclerotherapy needles
  • 5.2.9 Other gastrointestinal devices & accessories
• 5.3 Endoscopic retrograde cholangiopancreatography (ERCP) devices & accessories
  • 5.3.1 Metal stents
  • 5.3.2 Sphincterotome
  • 5.3.3 Guide wire
  • 5.3.4 Catheter
    • 5.3.4.1 Guiding catheter
    • 5.3.4.2 Dilation catheter
    • 5.3.4.3 Drainage catheter
    • 5.3.4.4 Other catheters
  • 5.3.5 Plastic stents
  • 5.3.6 Balloon dilation
  • 5.3.7 Extraction basket
  • 5.3.8 Extraction balloon
  • 5.3.9 Other ERCP devices & accessories
• 5.4 Other products

Chapter 6 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Gastrointestinal endoscopy
• 6.3 Laparoscopy
• 6.4 Arthroscopy
• 6.5 Urology endotherapy
• 6.6 Bronchoscopy
• 6.7 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgical centers
• 7.4 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 B. BRAUN
• 9.2 Boston Scientific
• 9.3 CONMED
• 9.4 Cook Medical
• 9.5 Endo-Med
• 9.6 FUJIFILM
• 9.7 Johnson & Johnson
• 9.8 KARL STORZ
• 9.9 M.I. Tech
• 9.10 Medtronic
• 9.11 MICRO-TECH
• 9.12 OLYMPUS
• 9.13 Smith+Nephew
• 9.14 Stryker
• 9.15 TAEWOONG MEDICAL